Extensive Circumferential Partial Thickness Sclerectomy in Nanophthalmic Eyes
|ClinicalTrials.gov Identifier: NCT03748732|
Recruitment Status : Active, not recruiting
First Posted : November 21, 2018
Last Update Posted : November 21, 2018
Purpose: To describe an extensive scleral excision technique to treat or prevent uveal effusion in nanophthalmic eyes.
Design: Prospective interventional case series.
- Setting: Institutional.
- Patient Population: Consecutive patients with nanophthalmos were operated on by one surgeon.
- Intervention Procedure: A single, 90% thickness scleral window extending from immediately behind the extraocular muscle insertions to the vortex veins was performed for 3 and 1/4 quadrants as a circumferential strip.
- Main Outcome Measure: Resolution or prevention of uveal effusion.
|Condition or disease||Intervention/treatment||Phase|
|Nanophthalmos||Procedure: sclerectomy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||30 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||surgery|
|Masking:||None (Open Label)|
|Official Title:||Extensive Circumferential Partial Thickness Sclerectomy in Nanophthalmic Eyes|
|Actual Study Start Date :||January 1, 2011|
|Estimated Primary Completion Date :||January 1, 2020|
|Estimated Study Completion Date :||January 1, 2020|
- Procedure: sclerectomy
scleral flapOther Name: maximal scleral excision
- resolution of uveal effusion [ Time Frame: 1 month ]disappearence of uveal effusion by OCT
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03748732
|Rafic Hariri University Hospital|
|Beirut, South Beirut, Lebanon, 1136044|
|Study Chair:||Ahmad Mansour, MD||Rafic Hariri University Hospital|